 Connection
Ana Gleisner to CA-19-9 Antigen
This is a "connection" page, showing publications Ana Gleisner has written about CA-19-9 Antigen.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.495 |
|
|
|
-
Yuza K, Kawashima J, Chatzipanagiotou OP, Hobeika C, Aucejo F, Marques HP, Hugh T, Shen F, Maithel SK, Koerkamp BG, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Poultsides G, Ruzzenente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Biologic stratification with tumor burden score and CA19-9 to inform vascular resection in intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2026 May; 52(5):111750.
Score: 0.236
-
Sugawara T, Rodriguez Franco S, Sherman S, Kirsch MJ, Colborn K, Franklin O, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer Database. Pancreatology. 2024 Dec; 24(8):1340-1347.
Score: 0.215
-
Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2022 01 01; 275(1):175-181.
Score: 0.044
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|